Cudone v. Gehret

821 F. Supp. 266, 1993 U.S. Dist. LEXIS 6682, 1993 WL 170628
CourtDistrict Court, D. Delaware
DecidedApril 29, 1993
DocketCiv. A. 91-585 MMS
StatusPublished
Cited by4 cases

This text of 821 F. Supp. 266 (Cudone v. Gehret) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cudone v. Gehret, 821 F. Supp. 266, 1993 U.S. Dist. LEXIS 6682, 1993 WL 170628 (D. Del. 1993).

Opinion

OPINION

MURRAY M. SCHWARTZ, Senior District Judge.

I. INTRODUCTION

Plaintiffs, Ann and Daniel Cudone, request this Court charge the jury on “increased *267 risk.” The request arises from plaintiffs’ assertion defendant, Dr. John F. Gehret, failed to adequately and timely diagnose Ms. Cudone’s breast cancer and that the delay in diagnosis resulted in metastasis of that cancer. Plaintiffs’ experts testified that based on a reasonable medical probability, Ms. Cu-done’s breast cancer would not have metastasized if there had been an earlier diagnosis. The experts also testified that based on a reasonable medical probability defendant’s negligence resulted in the progression of Ms. Cudone’s cancer from a “stage I” lesion to a “stage II” lesion with a concomitant increase in the chance that Ms. Cudone will experience a recurrence of her .cancer. The issue now before the Court is whether, plaintiffs may recover from defendants for this change in the statistical probability, i.e., “increased risk,” that Ms. 'Cudone’s cancer will recur. The Court holds that in the circumstances of this case a jury instruction on “increased risk” is appropriate.

II. DISCUSSION

A. Delineation of the Issue

The term “increased risk” has been the focus of numerous decisions with disparate results. Some of the confusion results from the failure to recognize that differing factual scenarios change the analysis of the issue.

The facts of the present ease áre as follows. One of plaintiffs’ experts, Dr. Mikund Didolkar, testified that if Ms. Cudone’s cancer had been diagnosed in October, of 1989, when she first sought defendant’s attention for a lump in her breast, the person doing the diagnosis would have identified a stage I cancer with no involvement of regional lymph nodes and no metastasis to distant organs. Dr. Didolkar testified that given the stage of her cancer in October of 1989, if her cancer had been treated at that timé, the probability that Ms. Cudone would have experienced a recurrence of her cancer in the following ten years would have been 25%-30%, if not less. Ms. Cudone’s cancer, however, was not diagnosed until July of 1990 at which time, according to Dr. Didolkar, her cancer had progressed to stage II. Given the stage of the cancer at the time of diagnosis, Dr. Didolkar assesses- Ms. Cudone’s chance of experiencing recurrence of her cancer within 10 years of diagnosis and treatment to be 50%-60%.

Plaintiffs also presented Dr. James Vogel as an expert. He testified that if Ms. Cu-done’s cancer had been diagnosed and treated in October of 1989 when it was at stage I, there would have been a 25% chance that Ms. Cudone’s cancer would have recurred and been the eventual cause of her death. Dr. Vogel also testified that because Ms. Cu-done’s cancer was not diagnosed and treated until July of 1990, when it had progressed to stage II, the chances that the disease will recur and result in Ms. Cudone’s' death are 55%. "

This testimony makes clear that the issue is whether there may be a recovery for an increase in the risk that a woman, now apparently cancer-free, will experience a recurrence of cancer as a result of alleged medical malpractice. This precise application of the concept of increased risk has not been explored by the Delaware courts. The Delaware Superior Court has, given the charge requested here in some cases and not in others. Yet, no rationale for the determinations have been given in pases similar to the instant one. In addition, there exist two lines of cases to which the term “increased risk” has. been applied. Analysis of these two lines of cases, however, reveals that neither, explores the .applicability of. the concept of increased risk in a factual context analogous to that presented in this ongoing trial. After consideration of these related decisions, the Court finds application of the concept of increased risk to be appropriate in the circumstances of the present case.

B. Existing Authority in Related Areas

1. Delaware Superior Court Charges on Increased Risk

The parties in this case have requested a jury charge, the appropriateness of which has been considered by the Superior Court of Delaware on a number of occasions. Judges of the Superior Court are divided on the appropriateness of the charge.

The charge requested by plaintiffs is as follows: ¡ 1

*268 Increased risk of harm is an element of damages that you may consider. You may award damages for an increased risk of a recurrence of cancer if the evidence established with a reasonable degree of medical probability that the defendants’ conduct caused such increase in the risk of recurrence. If you award damages for an increased risk of recurrence, you should take into account that there would have been some risk of recurrence even if Mrs. Cu-done’s cancer had been present in. 1989 and discovered and treated at that time. You may award damages only to the extent of any increase in the risk of recurrence resulting from medical malpractice.

Requests by plaintiffs to give this, or a similar charge, were granted in the recent cases of Wolf v. Papastavros, C.A. No. 90C-MR-154 (Del.Super.Ct. Dec. 10, 1992), Van Ostenbridge v. Brooks, C.A. No. 90C-02-004 (Del.Super.Ct. Sept. 10, 1992), Swede v. Cigna Health Plan of Delaware, Inc., C.A. No. 87C-SE-171 (Del.Super.Ct. Feb. 8, 1989), Lang v. Taylor, C.A. No. 86C-MY-184 (Del.Super.Ct. Sept. 1988), and Hubbard v. Robinson, C.A. 84C-AU-34 (Del.Super.Ct. June 9, 1987). The Superior Court refused to give such an- instruction in Hesseltine v. Wehner, C.A. No. 90C-AP-33 (Del.Super.Ct. Nov. 4, 1991) and in Shively v. Klein, C.A. No. 84C-JL-112, 1987 WL 16758 (Del.Super.Ct. August 28, 1987) (determining not to give requested charge in wrongful death action where charge as requested sought alteration in traditional standards of causation) aff'd, 551 A.2d 41 (Del.1988) (affirming determination not to give charge on basis opposing party had not been informed of this theory of plaintiffs case until trial already in progress).

It appears that the Superior Court in cases of the type before this Court, i.e. cases other than wrongful death actions, have been willing to give the charge. Wolf, C.A. No. 90C-MR-154 (medical malpractice suit involving breast cancer); Van Ostenbridge, C.A. No. 90C-02-004 (same); Lang, C.A. No. 86C-MY-184 (same). It is difficult, however, to precisely determine that court’s direction. The charge has been given in cases factually similar to the present case, but without supporting analysis. The only real published analysis of the issue was in a case concerning circumstances different from those before this Court. See Shively, C.A. No. 84C-JL-112, 1987 WL 16758 (Del.Super.Ct. August 28,1987) (charge not appropriate in wrongful death action where charge sought alteration in traditional standards of causation) aff'd,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

REPA v. NAPIERKOWSKI
W.D. Pennsylvania, 2022
Alexander v. Scheid
726 N.E.2d 272 (Indiana Supreme Court, 2000)
United States v. Anderson
669 A.2d 73 (Supreme Court of Delaware, 1995)
United States v. Cumberbatch
647 A.2d 1098 (Supreme Court of Delaware, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
821 F. Supp. 266, 1993 U.S. Dist. LEXIS 6682, 1993 WL 170628, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cudone-v-gehret-ded-1993.